These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 21268026

  • 21. Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers.
    Larhrib H, Martin GP, Prime D, Marriott C.
    Eur J Pharm Sci; 2003 Jul; 19(4):211-21. PubMed ID: 12885385
    [Abstract] [Full Text] [Related]

  • 22. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 23. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
    Kaialy W, Nokhodchi A.
    Int J Pharm; 2013 May 01; 448(1):58-70. PubMed ID: 23500603
    [Abstract] [Full Text] [Related]

  • 24. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Aug 01; 52(8):938-42. PubMed ID: 15304985
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D, Young PM, Jones M, Edge S, Price R.
    Eur J Pharm Sci; 2006 Feb 01; 27(2-3):243-51. PubMed ID: 16330191
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ, Worth Longest P, Hindle M.
    Int J Pharm; 2013 Feb 25; 443(1-2):137-45. PubMed ID: 23313343
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 33. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.
    He X, Li J, Wen X, Ma S, An Y, Zhang X, Guan J, Mao S.
    Int J Pharm; 2024 Oct 25; 664():124609. PubMed ID: 39163928
    [Abstract] [Full Text] [Related]

  • 34. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M, Kappl M, Butt HJ, Urbanetz NA, Lippold BC.
    Eur J Pharm Biopharm; 2007 Sep 25; 67(2):579-86. PubMed ID: 17418548
    [Abstract] [Full Text] [Related]

  • 35. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles.
    Gilani K, Najafabadi AR, Barghi M, Rafiee-Tehrani M.
    J Pharm Sci; 2005 May 25; 94(5):1048-59. PubMed ID: 15793812
    [Abstract] [Full Text] [Related]

  • 36. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W, Momin MN, Ticehurst MD, Murphy J, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Sep 01; 79(2):345-56. PubMed ID: 20537870
    [Abstract] [Full Text] [Related]

  • 37. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM, Chan HK, Chiou H, Edge S, Tee TH, Traini D.
    J Pharm Sci; 2007 May 01; 96(5):1331-41. PubMed ID: 17455362
    [Abstract] [Full Text] [Related]

  • 38. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
    Faulhammer E, Wahl V, Zellnitz S, Khinast JG, Paudel A.
    Int J Pharm; 2015 Aug 01; 491(1-2):231-42. PubMed ID: 26136200
    [Abstract] [Full Text] [Related]

  • 39. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G.
    Int J Pharm; 2009 Oct 01; 380(1-2):80-8. PubMed ID: 19596428
    [Abstract] [Full Text] [Related]

  • 40. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
    Jetmalani K, Young PM, Smith T, Stewart P, Traini D.
    Drug Dev Ind Pharm; 2012 Dec 01; 38(12):1504-11. PubMed ID: 22335558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.